OTOsamu Togao

Osamu Togao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Osamu Togao has a total of 225 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical and radiological features of fifteen patients presenting with concentric lesions like Baló's concentric sclerosis

    by Kazunori Iwao, Katsuhisa Masaki, Koji Shinoda, Mitsuru Watanabe, Yuu-Ichi Kira, Eizo Tanaka, Hajime Takeuchi, Ayano Matsuyoshi, Yukiko Inamori, Kazufumi Kikuchi, et al.

    Background: Baló's concentric sclerosis (BCS) is a rare demyelinating disorder defined by alternating rings of demyelinated and preserved myelin. Methods: We retrospectively reviewed the medical records of 15 Japanese patients with BCS lesions seen at our institution over a 15-year period. Results: The median age at onset was 29 years, with a female predominance (67%). All patients fulfilled the 2024 McDonald criteria for multiple sclerosis (MS), and 83% exhibited cerebrospinal fluid oligoclonal bands (OCBs). In patients who underwent susceptibility-weighted imaging, peripheral hypointensity was frequently observed, whereas classic lamellar architecture was not clearly visualized. Over long-term follow-up, new BCS lesions were detected during treatment with interferon beta, dimethyl fumarate, fingolimod, or siponimod, whereas no new BCS lesions were observed during natalizumab or ofatumumab exposure, except shortly after switching to natalizumab. Conclusions: These findings support the concept that BCS constitutes a clinical variant within the MS spectrum. Some patients appeared to benefit from natalizumab or ofatumumab, although the optimal DMT remains uncertain. The frequent presence of OCBs and MS-like radiological features may indicate overlap with classical MS. BCS may thus represent a common and distinct immune-mediated demyelinating phenotype at the interface between classical MS and atypical demyelination.

  • Open Access

    Quantitative Evaluation of Average Intensity Projection Images in Radiotherapy Planning for Primary Lung Cancer

    by Hiromu Nonaka, Noriyuki Nagami, Keiichi Ohira, Kenta Inoue, Osamu Togao

    【目的】Average intensity projection(AIP)法は4D-CTの各位相を加算平均して得る画像生成法である.本研究では,肺がんの呼吸性移動を評価したうえで,4D-CTの各位相輪郭の合算(4DTotal)を参照輪郭とし,3D-CT画像やmaximum intensity projection(MIP)画像,AIP画像から得られた輪郭の形状一致度を比較し,更に治療計画上の線量指標への影響を評価することで,AIP画像が腫瘍位置の時間依存的変位を包括した体積を幾何学的に近似できるかを評価することを目的とした.【方法】対象は当院で肺がんのstereotactic body radiotherapy(SBRT)を受けた8症例とした.初めに,4D-CTの10位相における腫瘍重心から運動特性を評価した.次に,各位相から抽出した輪郭を合算して4DTotalを作成し,4D-CTのAIPおよびMIP,3D-CTの低速撮影(3DSlow)の輪郭を,体積誤差,重心差,dice similarity coefficient(DSC),Jaccard index,95パーセンタイルHausdorff distance(HD95),mean surface distance(MSD),2 mmの許容距離閾値で算出したsurface DSCで比較した.また,各輪郭を用いて治療計画を作成し,Dmax(cGy),lung V5(%),lung V20(%),conformity index(CI),homogeneity index(HI)を比較した.【結果】腫瘍運動はinferior-superior(IS)方向が最大で,多方向に軌道を変えながら移動した.AIP画像では重心差≤1 mm,幾何学指標の中央値はDSC,Jaccard index,HD95,MSD,surface DSC(2 mm)でそれぞれ0.831,0.711,1.707 mm,0.451 mm,0.981であり,良好な幾何学的一致を示した.AIPとMIPの間に有意差は認めなかったが,AIPおよびMIPはいずれも3DSlowより良好であった.線量評価では,4群間の全体差はいずれの指標でも有意ではなかった.4DTotalを基準とした探索的な対応比較では,AIPでlung V20の低下方向,MIPでCIの増加方向の変化が観察された.ただし,これらの所見は確定的な結論としてではなく,限られた症例数に基づく探索的解析の結果として解釈する必要がある.【結語】AIP法は4DTotalに対して良好な幾何学的近似を示し,単一データセットで腫瘍の時間依存的変位を反映し得る可能性が示された.本研究の限られた探索的評価では,治療計画上の大きな不利は認められなかった.ただし,肺V20を含む線量指標の変化は線量的な優位性を示すものではなく,参照輪郭の不確実性や症例数の限界を踏まえ,臨床的有用性については今後更に検討が必要である.

  • Relaxometry assessment of meningioma consistency using quantitative magnetic resonance imaging

    by Kazufumi Kikuchi, Osamu Togao, Koji Yamashita, Daichi Momosaka, Masaoki Kusunoki, Daisuke Kuga, Ryusuke Hatae, Yutaka Fujioka, Ryosuke Otsuji, Fumiya Narutomi, et al.

    Purpose To determine whether relaxometry assessment using synthetic MRI (SyMRI) can predict meningioma consistency. Methods Eighteen patients with histologically confirmed meningioma were included, and all patients underwent quantitative MRI on a 3T MRI system using a 2D multi-dynamic multi-cho sequence. Quantitative MRI software version 11.3 (SyntheticMR AB, Linköping, Sweden) was used to generate quantitative maps of T1, T2 relaxation times and proton density (PD). Regions of interest were manually placed over all tumor slices to evaluate three parameters (T1, T2, PD). Comparing with the conventional method, relative values of the tumor-to-thalamus signal intensity ratio on the non-contrast T1-weighted image (T1R) and T2-weighted image (T2R) and apparent diffusion coefficients generated from b-values (0 and 1000 s/mm2) of the diffusion-weighted image were also evaluated. The 10th, 25th, 50th, 75th, and 90th percentiles and mean values were calculated using histogram analysis. Meningioma consistency was intraoperatively assessed by neurosurgeons using a standardized 5-point scale, with tumors classified as soft (scores 1–2) or hard (scores 3–5). The Mann–Whitney U test and receiver operating characteristic analysis were performed. Results Soft meningiomas showed significantly longer T1 and T2 relaxation times and higher PDs than hard meningiomas (median value, p-value: 2701 vs. 1721 ms, p = 0.0009 for T1; 111 vs. 94 ms, p = 0.0047 for T2; 92 vs. 85%, p = 0.0092 for PD, respectively). The 90th percentile of T1 relaxation time exhibited the highest diagnostic performance for differentiating soft from hard meningiomas. Conclusion Relaxometry assessment offers a reliable method for predicting meningioma consistency that can optimize surgical planning.


  • Estimation of organ and effective doses for rotational cerebral angiography using the National Cancer Institute Dosimetry System for Radiography and Fluoroscopy (NCIRF)

    by Hitoshi Miyazaki, Toshioh Fujibuchi, Donghee Han, Koji Oura, Takahiro Kosoegawa, Hiroshi Hamasaki, Hideki Yoshikawa, Koichi Arimura, Toyoyuki Kato, Kousei Ishigami, et al.

    Rotational cerebral angiography requires accurate dosimetry. The National Cancer Institute Dosimetry System for Radiography and Fluoroscopy (NCIRF), a Monte Carlo-based dosimetry software, can evaluate the organ dose (OD) and effective dose (ED) with higher accuracy than the conventional Monte Carlo software (PCXMC). We estimated the OD and ED for three-dimensional digital subtraction angiography (3D-DSA) and cone beam computed tomography (CBCT) using the NCIRF, reflecting dose variations during rotational cerebral angiography. The 3D-DSA and CBCT simulation parameters were obtained by rotational imaging of a physical head phantom using the Artis Q biplane system. The air kerma area product for each projection was determined based on the ratio of the tube current–time product for each projection; the NCIRF was used with male and female voxel-type reference computational phantoms. To validate the simulation results, the lens dose of the phantom was measured using radiophotoluminescence glass dosimeters and compared to the simulated lens dose. The highest ODs were delivered to the brain: 8.8 mGy (males) and 11.6 mGy (females) in 3D-DSA and 50.0 mGy (males) and 59.4 mGy (females) in CBCT. The EDs were 0.27 mSv (males) and 0.35 mSv (females) in 3D-DSA and 1.49 mSv (males) and 1.83 mSv (females) in CBCT. Lens doses differed within 8.0% between measurements and simulations, with 45.9–65.5% overestimation in simulations that did not account for dose variability. Simulations that considered dose variability using the NCIRF more accurately estimated OD and ED in rotational cerebral angiography.


  • Open Access

    Hybrid Multidelay PCASL Acquired With Time‐Encoded and Variable‐TR Schemes for the Assessment of Cerebral Perfusion in Moyamoya Disease

    by Osamu Togao, Makoto Obara, Koji Yamashita, Kazufumi Kikuchi, Tatsuhiro Wada, Chiaki Tokunaga, Ryoji Mikayama, Koichi Arimura, Ataru Nishimura, Shota Ishida, et al.

    Multidelay arterial spin labeling (ASL) MRI requires balancing temporal information with signal‐to‐noise ratio (SNR). A hybrid scheme combines the high SNR of time‐encoded pseudo‐continuous ASL (PCASL) with the temporal flexibility of variable‐TR PCASL. The purpose of the present study was to assess the SNR and quantitative performance of the hybrid scheme by comparing it to time‐encoded and variable‐TR schemes for evaluating cerebral perfusion in patients with moyamoya disease. Twenty patients with moyamoya disease (8 men and 12 women, 27.6 ± 22.7 years) were scanned with 3 T MRI system. Variable‐TR PCASL with 12 delays (vTR12), time‐encoded PCASL with seven delays (TEnc7), and hybrid PCASL with 12 (4 × 3) delays (Hyb12) were obtained. Hyb12 and vTR12 were configured with nearly identical label duration (LD) and postlabeling delay (PLD) settings. For TEnc7, it was balanced so that the maximum LD + PLD time is the same. Time‐corrected SNR (SNR t ), cerebral blood flow (CBF), and arterial transit time (ATT) were measured in vascular territories within gray matter. The three parameters were compared using the Friedman's matched test, followed by the Dunn's multiple comparison test. Correlations were evaluated with Pearson's correlation, and agreement was assessed by Bland–Altman plot analysis and intraclass correlation coefficient (ICC). The SNR t of Hyb12 (4.67 ± 1.97) was significantly higher than that of vTR12 (3.27 ± 1.37, p < 0.0001) and TEnc7 (3.52 ± 1.32, p < 0.0001). The CBF of Hyb12 (49.9 ± 13.7 mL/100 g/min) was significantly lower than that of vTR12 (54.9 ± 15.4 mL/100 g/min, p < 0.0001) and TEnc7 (57.5 ± 15.9 mL/100 g/min, p < 0.0001). The ATT of Hyb12 (1240 ± 430 ms) was significantly shorter than that of vTR12 (1474 ± 419 ms, p < 0.0001) and TEnc7 (1402 ± 333 ms, p < 0.0001). CBF and ATT measurements from Hyb12 showed strong correlations and good agreement with the other two schemes. The hybrid scheme offers higher SNR t than both time‐encoded and variable‐TR schemes, which may improve the accuracy of cerebral perfusion assessment in patients with cerebral artery occlusive diseases, where delayed blood flow is a concern.


  • Open Access

    Diffuse glioma with FGFR3::TACC3 gene fusion and prominent calcification: A case report

    by Masaoki Kusunoki, Osamu Togao, Koji Yamashita, Kazufumi Kikuchi, Daisuke Kuga, Yutaka Fujioka, Shun Akamine, Kousei Ishigami

  • Open Access

    Papillary Glioneuronal Tumor Located in the Subcortical White Matter With a Purely Solid Pattern: A Case Report

    by Masayuki Hirata, Osamu Togao, Koji Yamashita, Kazufumi Kikuchi, Masaoki Kusunoki, Fumiya Narutomi, Daisuke Kuga, Yutaka Fujioka, Koji Yoshimoto, Kousei Ishigami

    Papillary glioneuronal tumor (PGNT) is a rare brain tumor classified as a CNS WHO grade 1 tumor. It commonly occurs in the periventricular white matter and typically presents as a well-circumscribed mass composed of both cystic and solid components. In this report, we present a rare case of PGNT arising in the subcortical white matter and consisting entirely of solid components. Notably, a low-signal intensity rim was observed at the tumor margins on susceptibility-weighted imaging, a feature previously reported in PGNT. This finding may have diagnostic significance, as it could help differentiate PGNT from other tumors with overlapping imaging features, such as ganglioglioma, pleomorphic xanthoastrocytoma, and brain metastasis.


  • Open Access

    Correction to: Artificial intelligence-assisted volume isotropic simultaneous interleaved bright- and black-blood examination for brain metastases

    by Kazufumi Kikuchi, Osamu Togao, Yoshitomo Kikuchi, Koji Yamashita, Daichi Momosaka, Kazunori Fukasawa, Shunsuke Nishimura, Hiroyuki Toyoda, Makoto Obara, Akio Hiwatashi, et al.

  • The cortical high-flow sign in oligodendroglioma, IDH-mutant and 1p/19q-codeleted is correlated with histological cortical vascular density

    by Koji Yamashita, Ryo Murayama, Masahiro Itoyama, Kazufumi Kikuchi, Masaoki Kusunoki, Daisuke Kuga, Ryusuke Hatae, Yutaka Fujioka, Ryosuke Otsuji, Nobuhiro Fujita, et al.

    Background and purpose The cortical high-flow sign has been more commonly reported in oligodendroglioma, IDH-mutant and 1p/19q-codeleted (ODG IDHm-codel) compared to diffuse glioma with IDH-wildtype or astrocytoma, IDH-mutant. Besides tumor types, higher grades of glioma might also contribute to the cortical high flow. Therefore, we investigated whether the histological cortical vascular density or CNS WHO grade was associated with the cortical high-flow sign in patients with ODG IDHm-codel. Materials and methods This retrospective study consisted of pathologically confirmed 25 adult patients with ODG IDHm-codel. We implemented pseudo-continuous arterial spin labeling technique with background suppression. Subtraction images were generated from paired control and label images. Tumor-affecting cortices without intense contrast enhancement on conventional MR imaging were targeted for the determination of the cortical high-flow sign. Immunohistochemical staining of CD31 antibody was performed for the identification of vascular endothelial cells. A microscopic field of the most intense vascularization was captured in each specimen. The vessel number and the relative vascular density (%Vessel) were compared between the positive cortical high-flow sign (CHFS+) and the negative cortical high-flow sign (CHFS−) groups using the Mann–Whitney U test. Second, Fisher’s exact test was used to compare the difference between the presence or absence of cortical high-flow sign and CNS WHO grades. Finally, the vessel number and %Vessel were compared between the CNS WHO grade 2 and grade 3 using the Mann–Whitney U test. Results The vessel number and %Vessel were higher in patients with the CHFS+ group than in patients with CHFS− group (p = 0.016 and p = 0.005, respectively). We observed no significant differences (p = 1.00) in the frequency of cortical high-flow sign between the CNS WHO grade 2 and grade 3. In addition, no significant differences are found in the vessel number and %Vessel between the CNS WHO grade 2 and grade 3 (p = 0.121 and p = 0.475, respectively). Conclusion The cortical high-flow sign on ASL, which is more commonly found in ODG IDHm-codel than in diffuse glioma with IDH-wildtype or astrocytoma, is associated with the histological cortical vascular density in patients with ODG IDHm-codel.


  • Open Access

    Improving Vessel Visibility and Applying Artificial Intelligence to Autodetect Brain Metastasis for a 3D MR Imaging Sequence Capable of Simultaneous Images with and without Blood Vessel Suppression

    by Kazufumi Kikuchi, Makoto Obara, Yoshitomo Kikuchi, Koji Yamashita, Tatsuhiro Wada, Akio Hiwatashi, Kousei Ishigami, Osamu Togao

    Purpose: The purposes of this study were 1) to improve vessel visibility of our MR sequence by modifying k-space filling and 2) to verify the usefulness of applying artificial intelligence (AI) for volume isotropic simultaneous interleaved bright- and black-blood examination (VISIBLE) with compressed sensitivity encoding (CS) in autodetecting brain metastases.Methods: We modified 3 sequences of VISIBLE (Centric, Reversed Centric, and Startup Echo 30). The Centric sequence is a prototype. The Reversed Centric filled the k-space in a reversed centric manner to improve vessel visibility. The Startup Echo 30 implemented dummy echoes to further improve vessel visibility. Vessel visibility was evaluated in one slice at the level of the centrum semiovale. The sensitivity, specificity, the area under the curve (AUC), and false positives of detecting brain metastases using AI were evaluated among 3 sequences. Statistical comparisons were performed using a one-way analysis of variance, followed by Friedman and Dunn’s multiple comparison tests.Results: The number of visualized vessels was significantly lower in the Centric (39.3 ± 9.7, P < 0.05) and Reversed Centric (44.2 ± 9.8, P < 0.05) methods than in the magnetization-prepared rapid gradient echo (49.3 ± 9.1) but comparable in the Startup Echo 30 method (44.9 ± 8.8, P > 0.05). No significant differences existed in sensitivity, specificity, and AUC among the 3 methods. False positives achieved using the Reversed Centric method were significantly fewer (54 false positives) than those achieved using the Centric (85 false positives) and Startup Echo 30 (68 false positives) methods (P = 0.0092).Conclusion: Vessel visibility was improved by modifying the k-space filling, which may reduce false positives. The AI model for VISIBLE with CS achieved good performance in autodetection of brain metastases. The AI model for VISIBLE with CS can help radiologists diagnose brain metastases in clinical practice.